CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc., a company singularly dedicated to addressing unsolved problems in stroke, today announced that its Chief Operating Officer, Daniel Davis, has been appointed as the company’s President. Mr. Davis will oversee the growth of the company’s technology portfolio for the treatment of ischemic and hemorrhagic stroke. He will retain his role as COO and join the company’s Board of Directors.
Mr. Davis has more than 20 years of experience in sales, marketing, and business development with both early stage and Fortune 500 medical devices companies, with much of his experience focused on bringing neurovascular innovations to market. Prior to joining Imperative Care in 2019, Mr. Davis served as Chief Commercial Officer and President of North America at Penumbra, Inc., where he led the launch of the first FDA-cleared aspiration system for neurovascular mechanical thrombectomy.
“It’s been a real pleasure working with Daniel and benefiting from his steadfast commitment to elevating stroke care which has enabled him to make significant contributions from the outset of his time at Imperative Care. I am thrilled to see his leadership grow within the organization as he now oversees our efforts to bring much-needed innovation to the field of stroke,” said Fred Khosravi, Imperative Care’s founding Chairman and CEO.
“Many of us at Imperative Care are driven by our personal connection to stroke and the pursuit of better, more streamlined care for stroke patients and their families,” said Mr. Davis. “Imperative Care’s resolute dedication to innovation across the continuum of stroke care has been inspirational to me. I am convinced that this will position the company to revolutionize the stroke space and excited to continue leading the company alongside Fred and our seasoned leadership team.”
Imperative Care is currently commercializing two platforms that offer physicians new capabilities to treat their patients, the industry’s first Large Distal Platform™ (LDP™) access technology, including TracStar LDP™, and unparalleled thrombectomy technology, the Zoom™ Stroke Solution. The company is also developing a pipeline of additional stroke-care innovations.
Stroke remains a largely unaddressed problem that affects over 800,000 Americans each year.1 Treatment options have significantly improved over the last decade, but the need for improved effectiveness and efficiency remains. Imperative Care aims to invest significantly in clinical evidence to advance the standard of care for stroke patients worldwide.
About Imperative Care, Inc.
Based in Campbell, Calif., Imperative Care is speeding new answers to stroke by developing a portfolio of innovative solutions to address the vast and urgent unmet needs in stroke care. The company is singularly dedicated to improving the way stroke is treated by advancing medical technology, equipping healthcare providers to evolve best practices and elevate the standard of care for stroke patients. For more information, visit http://www.imperativecare.com/.
1Mozzafarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al., on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation 2016;133(4):e38–360.